Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome

Overview of attention for article published in Journal of the American Society of Nephrology, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 54 X users
facebook: 1 Facebook page

f1000: 1 research highlight platform
guideline: 2 clinical guideline sources

Readers on

mendeley: 83 Mendeley

So far, Altmetric has seen 56 X posts from 54 X users, with an upper bound of 243,070 followers.

RT @mmvidas: #Eculizumab pretrasplante tras estratificación riesgo de SHUa en el receptor 👉🏻sin duda “un antes y un después” para este subg…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 52 additional X posts.